Elevate Your Research
Appetite Control • Metabolic Optimization • Triple Agonist
G3-R (Reta) represents the most advanced evolution in peptide-based metabolic research. Engineered as a triple-agonist compound, it is designed to engage three critical regulatory pathways—GLP 1, GIP, and glucagon receptors—within energy balance and substrate utilization systems. This multi-pathway activation profile distinguishes G3-R as a next-generation compound in body-composition and metabolic optimization research.
Unlike single- or dual-agonist peptides, G3-R is structured to influence both intake signaling and energy expenditure mechanisms, positioning it as a peak-performance option in advanced peptide development.
Key Areas of Research Interest
Simultaneous activation of GLP 1, GIP, and glucagon receptor pathways
Upregulation of metabolic rate–associated signaling
Enhanced lipid oxidation pathways with preserved structural tissue signaling
High-precision multi-hormonal pathway engagement
Demonstrated efficacy in overcoming metabolic adaptation observed in prior agonist models
Mechanism of Action
G3-R operates through a triple-agonist signaling framework. Activation of GLP 1 and GIP receptor pathways supports regulated energy intake signaling and glucose-related pathway efficiency. Its additional engagement of glucagon receptors differentiates the compound by promoting increased energy expenditure signaling and enhanced lipid mobilization pathways.
This integrated mechanism shifts focus beyond isolated appetite-related pathways toward system-level metabolic modulation. Comparative research data indicate G3-R demonstrates greater overall reductions in adipose-associated markers when evaluated against dual-agonist compounds such as G1-S and G2-T, particularly in models assessing central and visceral fat signaling.
Product Specifications
Compound Type: Triple-agonist peptide
Classification: GLP 1 / GIP / Glucagon receptor agonist
Administration Route: Subcutaneous (weekly protocol observed in studies)
Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight: 4,731.33 g/mol
Estimated Half-Life: 5–7 days
Development Status: Late-stage clinical research
Research Focus: Metabolic signaling, energy balance modulation, adipose tissue regulation
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose treat cure or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. This compound should only be handled by qualified professionals in appropriate research or laboratory settings.
Metabolic Optimization
Tissue Repair • Gut Health Support • Injury Recovery
Body Protection Compound 157 (BPC-157) is a synthetic peptide research compound derived from a naturally occurring protein fragment identified in gastric juice. It has been extensively examined in laboratory and preclinical research settings for its role in cellular repair signaling, tissue integrity pathways, and gastrointestinal system related mechanisms.
Within research literature, BPC-157 is frequently referenced for its interaction with angiogenic processes and cellular signaling pathways associated with tissue maintenance and regeneration. Due to its stability and well defined amino acid sequence, it is commonly utilized in studies involving soft tissue models, connective tissue research, and digestive system investigations.
Key Areas of Research Interest
Cellular repair and tissue regeneration pathways
Angiogenesis and vascular signaling mechanisms
Inflammatory response modulation
Gastrointestinal integrity and mucosal protection research
Recovery related biochemical signaling pathways
Mechanism of Action
BPC-157 is studied for its ability to influence angiogenic signaling and cellular communication pathways involved in tissue maintenance. Research indicates that the compound may interact with nitric oxide pathways, growth factor signaling, and cytoprotective mechanisms relevant to tissue resilience and repair.
In laboratory models, BPC-157 has demonstrated stability in gastric environments, contributing to its frequent examination in gastrointestinal research. Its role in modulating inflammatory signaling and cellular stress responses has made it a compound of interest across a wide range of regenerative and recovery focused studies.
Product Specifications
Compound Type: Synthetic peptide research compound
Form: Lyophilized powder
CAS Number: 137525 51 0
Amino Acid Sequence: Gly Glu Pro Pro Pro Gly Lys Pro Ala Asp Asp Ala Gly Leu Val
Molecular Weight: Approximately 1419.54 g mol
Research Application: Tissue regeneration and gastrointestinal pathway studies
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose treat cure or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. This compound should only be handled by qualified professionals in appropriate research or laboratory settings.
Tissue Regeneration
Muscle Recovery • Mobility Support • Tissue Repair
TB-500 is a synthetic peptide research compound modeled after Thymosin Beta 4, a naturally occurring peptide involved in cellular organization and tissue related signaling pathways. It is widely studied in laboratory and preclinical research settings for its role in cytoskeletal regulation, cell migration, and angiogenic processes.
Within scientific literature, TB-500 is frequently examined for its influence on actin binding dynamics, vascular development pathways, and connective tissue related cellular signaling. Its broad biological activity and well characterized structure have made it a compound of interest in studies involving tissue integrity, repair signaling, and recovery related mechanisms.
Key Areas of Research Interest
Cell migration and cytoskeletal organization pathways
Angiogenesis and vascular development signaling
Inflammatory response modulation
Connective tissue and musculoskeletal research models
Cellular stress response and repair related signaling
Mechanism of Action
TB-500 is studied for its interaction with actin regulation and intracellular signaling pathways that influence cellular movement and structural organization. Thymosin Beta 4 related compounds have been shown in research settings to play a role in endothelial cell migration, vascular formation signaling, and modulation of inflammatory pathways.
In laboratory models, TB-500 is often examined alongside other regenerative focused research compounds to evaluate overlapping or complementary signaling mechanisms within tissue repair and recovery pathways. Its ability to interact with multiple cellular systems has positioned it as a widely referenced compound in regenerative and connective tissue research.
Product Specifications
Compound Type: Synthetic peptide research compound
Form: Lyophilized powder
CAS Number: 77591 33 4
Amino Acid Sequence: Ac Leu Lys Lys Thr Glu Thr Gln
Molecular Weight: Approximately 4963.44 g mol
Research Application: Cellular migration and tissue signaling studies
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose treat cure or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. This compound should only be handled by qualified professionals in appropriate research or laboratory settings.
Muscle Recovery
Inflammation Control • Immune Support • Gut Barrier Support
Lysine-Proline-Valine (KPV) is a naturally occurring tripeptide derived from the alpha-melanocyte-stimulating hormone (α-MSH) sequence and is widely studied in inflammatory regulation and gut-associated signaling pathways.
Within research environments, KPV has drawn attention for its role in supporting balanced inflammatory responses and promoting cellular environments associated with tissue resilience and barrier integrity. Because of its targeted signaling properties, KPV has become a focus in research exploring immune modulation, gastrointestinal health models, and skin-related recovery pathways.
By interacting with regulatory pathways tied to cytokine signaling and inflammatory response control, KPV continues to serve as a valuable compound in next-generation research exploring immune balance, epithelial barrier support, and tissue-recovery environments.
Key Areas of Research Interest
Helps support a balanced inflammatory response within the body
Assists in supporting overall tissue recovery and cellular repair environments
Helps the body manage and bring down excessive inflammatory responses
Supports gut health and intestinal barrier function
Promotes a healthier environment for skin recovery and irritation support
Mechanism of Action
KPV functions as a short signaling peptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). This tripeptide has demonstrated the ability to influence inflammatory signaling pathways, particularly those associated with cytokine activity and immune response regulation.
Research suggests KPV may help modulate pathways tied to NF-κB signaling and other inflammatory mediators involved in immune-system communication. Through these mechanisms, the peptide has been studied for its ability to support balanced inflammatory environments within gastrointestinal, dermal, and epithelial tissue models.
Because of its targeted signaling properties and relatively small peptide structure, KPV has become an increasingly studied compound in research involving gut-barrier function, immune balance, microbial ecosystem signaling, and tissue-recovery pathways
Product Specifications
Compound Type: Anti-inflammatory signaling tripeptide
Classification: Immune-regulation research peptide
Primary Structure: Lysine-Proline-Valine
Molecular Formula: C₁₆H₂₈N₄O₄
Molecular Weight: ~340.42 g/mol
Administration Route: Subcutaneous, topical, or oral research models observed in studies
Stability Profile: Stable short-chain peptide structure
Development Status: Active research phase
Research Focus: Inflammatory signaling regulation, gut-barrier research, immune modulation pathways, microbial balance models, and tissue-recovery studies
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose treat cure or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. This compound should only be handled by qualified professionals in appropriate research or laboratory settings.
Inflammation Control
Collagen Production • Skin & Hair Health • Tissue Repair
Commonly referred to in research literature as GHK Copper, GLOW is a naturally occurring tripeptide complex studied for its role in cellular signaling, tissue remodeling pathways, and regenerative biochemical processes. It is formed by the binding of the peptide sequence GHK with copper ions, creating a stable complex frequently examined in dermatological, connective tissue, and cellular aging research models.
GHK Copper has been widely investigated for its interaction with gene expression pathways, extracellular matrix regulation, and cellular repair signaling. Due to its broad biological relevance, it is often included in laboratory studies involving tissue quality, structural integrity, and oxidative stress modulation.
Key Areas of Research Interest
Cellular regeneration and tissue remodeling pathways
Collagen synthesis and extracellular matrix signaling
Angiogenesis and vascular support mechanisms
Anti inflammatory and oxidative stress modulation
Skin structure connective tissue and cellular aging research
Mechanism of Action Overview
GHK Copper is studied for its ability to bind copper ions and facilitate their role in enzymatic and cellular signaling processes. Research indicates that this complex may influence gene expression related to tissue repair, collagen production, and antioxidant defense systems.
In laboratory models, GHK Copper has demonstrated involvement in signaling pathways associated with cellular renewal, inflammatory response modulation, and matrix organization. Its interaction with copper dependent enzymes has positioned it as a compound of interest in studies focused on tissue resilience, regeneration signaling, and structural maintenance at the cellular level.
Product Specifications
Compound: Type Peptide copper complex research compound
Form: Lyophilized powder
Chemical Composition: GHK peptide complexed with copper
Molecular Weight: Approximately 403.93 g mol
Appearance: Blue to blue green lyophilized solid
Research Application: Cellular regeneration and tissue signaling studies
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose treat cure or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. This compound should only be handled by qualified professionals in appropriate research or laboratory settings.
Collagen Production
Cellular Energy Production • Healthy Aging Pathways • Metabolic Support
NAD+ is a naturally occurring coenzyme studied extensively for its role in cellular energy metabolism, mitochondrial function, and redox balance. It is a central molecule in biological research due to its involvement in fundamental cellular processes related to energy production and metabolic regulation.
Within laboratory and preclinical research, NAD+ is commonly examined for its role in cellular resilience, metabolic efficiency, and age related biochemical pathways. Due to its essential function across multiple biological systems, it is frequently included in studies focused on cellular performance and energy related signaling mechanisms.
Key Areas of Research Interest
Cellular energy metabolism and ATP related signaling pathways
Mitochondrial function and bioenergetic efficiency research
Oxidative stress regulation and redox balance mechanisms
Cellular aging and longevity related biochemical pathways
Metabolic resilience and cellular repair signaling studies
Mechanism of Action
NAD+ functions as a critical cofactor in oxidation reduction reactions that drive cellular energy production. It plays a key role in mitochondrial respiration, DNA repair related signaling, and enzymatic processes involved in metabolic regulation.
In research models, NAD+ availability has been shown to influence sirtuin activity, PARP related pathways, and mitochondrial signaling mechanisms associated with cellular stress response and energy balance. These interactions have positioned NAD+ as a foundational compound in studies exploring cellular efficiency, metabolic health, and age associated biochemical changes.
Product Specifications
Compound: Type Coenzyme research compound
Form: Lyophilized powder
Chemical Name: Nicotinamide Adenine Dinucleotide
Molecular Weight: Approximately 663.43 g mol
Appearance: White to off white lyophilized solid
Research Application: Cellular energy and metabolic pathway studies
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose treat cure or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. This compound should only be handled by qualified professionals in appropriate research or laboratory settings.
Healthy Aging
Energy Production • Endurance Support • Metabolic Efficiency
MOTS-C is a mitochondrial-derived peptide that has gained attention in metabolic and cellular energy research. Unlike many peptides that originate from nuclear DNA, MOTS-C is encoded within mitochondrial DNA and is involved in signaling pathways related to energy production and metabolic balance.
Because mitochondria are responsible for producing energy inside our cells, MOTS-C has become an important focus in research exploring metabolism, endurance, and how the body adapts to physical stress. Researchers are particularly interested in how this peptide may influence the way cells use energy, regulate glucose, and maintain metabolic efficiency.
Through its interaction with pathways such as AMPK activation, MOTS-C continues to be studied for its role in supporting cellular energy regulation, metabolic function, and the body’s ability to adapt to physical and metabolic demands.
Key Areas of Research Interest
Improves endurance and physical performance
Supports cellular resilience and adaptation to metabolic and physical stress
Supports healthy cellular energy production and mitochondrial efficiency
Assists in supporting metabolic balance and energy utilization within cells
Helps the body manage glucose metabolism and metabolic signaling pathways
Mechanism of Action
MOTS-C functions as a mitochondrial signaling peptide that helps communicate between mitochondria and the nucleus to regulate metabolic pathways. Research suggests it may activate AMPK (AMP-activated protein kinase), a key metabolic regulator involved in energy balance, glucose uptake, and cellular stress response.
Through these mechanisms, MOTS-C has been studied for its potential role in improving metabolic efficiency, supporting insulin sensitivity signaling, and helping cells utilize energy more effectively during periods of metabolic demand such as exercise or caloric restriction.
Because of its connection to mitochondrial signaling and metabolic regulation, MOTS-C has become an increasingly studied peptide in research focused on endurance adaptation, energy metabolism, and cellular longevity pathways.
Product Specifications
Compound Type: Mitochondrial-derived signaling peptide
Classification: Metabolic regulation research peptide
Molecular Formula: C₁₀₁H₁₅₂N₂₈O₂₂S₂
Molecular Weight: ~2174 g/mol
Administration Route: Subcutaneous injection in research settings
Stability Profile: Peptide requiring proper cold storage for stability
Development Status: Active research phase
Research Focus: Metabolic signaling, mitochondrial function, glucose metabolism, endurance research, and cellular energy pathways
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose treat cure or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. This compound should only be handled by qualified professionals in appropriate research or laboratory settings.
Energy & Endurance
Appetite Control • Weight Management • Dual Agonist
G2-T (Tirz) represents a significant advancement in peptide-based metabolic research, positioned as a dual-agonist compound engineered to engage two primary incretin pathways—GLP 1 and GIP receptors. This dual-pathway design builds upon earlier single-agonist frameworks, offering enhanced regulatory control within energy intake, glucose-related signaling, and adipose metabolism research models.
Through coordinated receptor engagement, G2-T is structured to support more efficient metabolic signaling than first-generation incretin compounds, making it a key developmental step within next-phase peptide optimization research.
Key Areas of Research Interest
Dual activation of GLP 1 and GIP receptor pathways
Enhanced regulation of energy intake–associated signaling
Improved glucose utilization and insulin-related pathway efficiency
Support for metabolic balance during adaptive plateaus
Demonstrated advancement over single-agonist peptide models in comparative studies
Mechanism of Action
G2-T functions as a dual incretin receptor agonist, simultaneously activating GLP 1 and GIP signaling pathways. These pathways are central to metabolic regulation research, influencing glucose-dependent signaling, energy intake modulation, and lipid storage dynamics.
By integrating both receptor actions into a single molecular structure, G2-T demonstrates greater signaling efficiency than GLP 1–only compounds such as G1-S. Comparative research has shown improved outcomes across multiple metabolic markers, including adipose-related measurements and glucose-associated endpoints, highlighting its role as an intermediary advancement between single- and triple-agonist peptide development.
Product Specifications
Compound Type: Dual-agonist peptide
Classification: GLP 1 / GIP receptor agonist
Administration Route: Subcutaneous (weekly protocols observed in studies)
Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight: ~4,813.03 g/mol
Estimated Half-Life: ~5 days
Development Status: Advanced clinical research
Research Focus: Metabolic signaling, glucose regulation pathways, adipose modulation
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose treat cure or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. This compound should only be handled by qualified professionals in appropriate research or laboratory settings.
Blood Sugar Control • Appetite & Weight Management
G1-S (Sema) is a peptide-based research compound widely studied for its role in appetite regulation, glucose metabolism, and energy balance pathways. It is commonly positioned as a foundational compound within metabolic and weight regulation research models, serving as an entry point for GLP 1 receptor focused investigations.
As a GLP 1 receptor agonist, G1-S is frequently examined for its influence on appetite signaling pathways, insulin response, and gastric emptying mechanisms. Its extended half life and once weekly administration profile make it a reference compound in long term metabolic and endocrine research protocols, often preceding more complex dual or triple agonist studies.
Key Areas of Research Interest
Appetite signaling and intake regulation pathways
Satiety signaling and delayed gastric emptying mechanisms
Insulin response modulation and glucose stability
Metabolic efficiency and fat mass related research
Energy balance and glycemic control pathways
Mechanism of Action
G1-S functions by mimicking the activity of endogenous GLP 1, a hormone involved in glucose dependent insulin secretion, appetite signaling, and digestive rate modulation. GLP 1 receptor activation has been shown in research settings to influence central nervous system signaling related to food intake while also affecting peripheral glucose regulation.
Rather than acting as a direct satiety agent, G1-S is studied for its role in modulating neurohormonal pathways associated with appetite suppression, delayed gastric emptying, and metabolic signaling. These mechanisms have made it a cornerstone compound in metabolic research and a baseline comparator in GLP 1 related studies.
Extensive clinical and laboratory research has established G1-S as a well characterized compound within the GLP 1 class, frequently utilized in ongoing metabolic and endocrine investigations.
Product Specifications
Compound Type: Peptide based research compound
Compound Class: GLP 1 receptor agonist
Administration Route: Subcutaneous injection
Molecular Formula: C187H291N45O59
Molecular Weight: Approximately 4113.58 g mol
Half Life: Approximately 7 days
Research Application: Metabolic and glucose regulation studies
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose treat cure or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. This compound should only be handled by qualified professionals in appropriate research or laboratory settings.
Weight Management
Appetite Control
Collagen Production • Skin & Hair Health • Tissue Repair
Copper Tripeptide Complex (GHK-Cu) is a well-established copper-binding peptide complex widely studied in regenerative and cellular signaling research. Naturally occurring in the human body, this tripeptide–copper complex has been extensively studied for its role in supporting tissue repair signaling, skin-associated structural pathways, and overall cellular maintenance.
Within research environments, GHK-Cu is recognized for its ability to interact with gene expression pathways tied to collagen production, antioxidant activity, and structural protein support. Its multifunctional profile has made it a core compound in studies exploring dermal resilience, recovery signaling, and long-term tissue optimization.
By supporting communication between repair-related cellular pathways and structural protein systems, GHK-Cu continues to serve as a foundational peptide in next-phase research centered around skin quality, follicular support, and connective tissue maintenance.
Key Areas of Research Interest
Supports smoother, firmer skin-related research pathways
Helps promote collagen and elastin activity signals
Encourages healthy hair and scalp research environments
Supports tissue recovery and repair signaling
Helps maintain a balanced inflammation response in studies
Boosts antioxidant and cellular protection pathways
Plays a role in overall skin quality and structural support research
Mechanism of Action
GHK-Cu functions as a copper-binding signaling peptide that delivers bioavailable copper to targeted cellular pathways. Copper plays a critical role in multiple enzymatic and structural processes, including collagen formation, antioxidant defense, and tissue repair signaling.
When bound to copper, the GHK peptide becomes highly active in cellular communication pathways involved in regeneration and structural maintenance. Research indicates that this complex can influence gene expression related to collagen production, extracellular matrix remodeling, and angiogenesis-associated signaling.
GHK-Cu has also demonstrated the ability to support balanced inflammatory signaling and oxidative-stress defense pathways, both of which are essential for maintaining tissue integrity and long-term cellular resilience. These combined effects position the peptide as a central compound in advanced dermal, follicular, and connective-tissue research models.
Product Specifications
Compound Type: Copper-binding tripeptide complex
Classification: Regenerative signaling peptide
Primary Structure: Glycyl-L-histidyl-L-lysine copper complex
Molecular Formula: C₁₄H₂₄N₆O₄Cu
Molecular Weight: ~403.93 g/mol
Administration Route: Subcutaneous or topical application observed in research settings
Stability Profile: High stability copper-peptide complex
Development Status: Advanced research phase
Research Focus: Skin remodeling pathways, collagen support signaling, follicular research, antioxidant activity, and tissue recovery models
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. This compound should only be handled by qualified professionals in appropriate research or laboratory settings.
Growth Hormone Release • Recovery Optimization • Lean Mass Development
CJC-1295 / Ipamorelin is a dual-peptide formulation commonly used in growth hormone pathway research. By combining a growth hormone releasing hormone analog with a selective ghrelin receptor agonist, this pairing works through complementary signaling mechanisms involved in natural growth hormone release.
This peptide combination is frequently used in research settings focused on recovery processes, sleep quality pathways, and body composition signaling. The coordinated interaction between CJC-1295 and Ipamorelin allows for investigation into balanced growth hormone pulse activity and downstream metabolic pathways.
Key Areas of Research Interest
Supports natural growth hormone signaling linked to recovery and physical performance
Helps the body recover faster after intense training or physical stress
Promotes deeper sleep and supports overnight repair processes
Supports lean muscle maintenance while helping regulate fat metabolism
Helps maintain balanced and consistent growth hormone release patterns
Mechanism of Action
CJC-1295 functions as a growth hormone releasing hormone analog that interacts with receptors responsible for stimulating growth hormone signaling pathways. Ipamorelin acts as a selective ghrelin receptor agonist that promotes growth hormone pulse activity through a separate but complementary mechanism.
When combined, these peptides influence two different regulatory pathways associated with endogenous growth hormone release. This dual-pathway activity allows researchers to examine coordinated signaling related to recovery processes, metabolic function, and regenerative biological pathways.
Product Specifications
Compound: CJC-1295 / Ipamorelin Peptide Blend
Form: Lyophilized Powder
Chemical Name: CJC-1295 (Modified Growth Hormone Releasing Hormone Analog)
Ipamorelin (Pentapeptide Growth Hormone Secretagogue)
Molecular Weight: CJC-1295: ~3647.2 g/mol Ipamorelin: ~711.9 g/mol
Appearance: White to off-white sterile lyophilized powder
Research Application: Growth hormone secretagogue research, metabolic pathway studies, recovery signaling analysis, and peptide interaction research.
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose treat cure or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. This compound should only be handled by qualified professionals in appropriate research or laboratory settings.
Lean Mass
Skin & Hair Health